AU Stock MarketDetailed Quotes
NOX Noxopharm Ltd
- 0.110
- +0.005+4.76%
20min DelayMarket Closed Oct 16 13:14 AET
32.15MMarket Cap-9166P/E (Static)
0.115High0.105Low407.56KVolume0.110Open0.105Pre Close44.33KTurnover0.14552wk High0.22%Turnover Ratio292.24MShares0.05152wk Low-0.012EPS TTM20.88MFloat Cap1.590Historical HighLossP/E (Static)189.86MShs Float0.033Historical Low-0.012EPS LYR9.52%Amplitude--Dividend TTM5.79P/B1Lot Size--Div YieldTTM
About Noxopharm Ltd Company
Noxopharm Ltd is an Australian clinical-stage drug development company focused on discovering and developing novel treatments for cancer and inflammation, as well as improving mRNA vaccines, based on two preclinical platforms. It is engaged in one segment which is the clinical development in the field of both oncology and non-oncology in the pan-pacific region.
Company Profile
SymbolNOX
Company NameNoxopharm Ltd
Founded2015
MarketASX
Fiscal Year Ends06-30
Address60 Linksley Ave
CityGlenhaven
CountryAustralia
Zip Code2156
Websitehttps://www.noxopharm.com
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Gisela Mautner
- Chief Executive Officer,Managing Director
- --
- Peter Ashley Marks
- Non-Executive Director,Non-Executive Deputy Chairman
- --
- Frederick (Fred) Bart
- Non-Executive Director,Non-Executive Chairman
- --
- Boris Patkin
- Non-Executive Director
- --
Analysis
Price Target
No Data
Heat List
AU
Overall
Symbol
Latest Price
% Chg
No Data